Accuray Continues Global Expansion in South Asia and Announces the First Two CyberKnife® VSI™ Systems in India

Accuray Continues Global Expansion in South Asia and Announces the First Two CyberKnife® VSI™ Systems in India PR Newswire SUNNYVALE, California, Nov. 21, 2012 SUNNYVALE, California, Nov. 21, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today that Medanta - The Medicity Cancer Institute, and the Roentgen-BLK Super Speciality Hospital both recently acquired and started treating patients with the CyberKnife® VSI™ System the premier solution for full-body radiosurgery marking the first-in-country CyberKnife VSI Systems in India. Cancer incidence is growing in India with 900,000 new cancer cases and 400,000 cancer deaths annually. Cancers account for eight percent of total deaths in India thus creating a larger demand for cancer treatments. By enriching their therapeutic offerings in radiation oncology, Medanta - The Medicity Cancer Institute and the Roentgen-BLK Radiation Oncology Center can now provide patients treatment with the CyberKnife System and expand the patient population that can now benefit from CyberKnife radiosurgery and stereotactic body radiation therapy (SBRT) in the region. "The CyberKnife System is increasingly being used as an alternative to conventional radiation therapy in situations where its targeting accuracy allows a shorter and more intense course of radiation, including radiosurgery for brain tumors.